Literature DB >> 8030225

Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

R E Lanford1, C Sureau, J R Jacob, R White, T R Fuerst.   

Abstract

Analysis of hepatitis C virus (HCV) replication has been hampered due to the difficulty encountered in in vitro cultivation of the virus in conventional tissue culture systems. In this study, primary chimpanzee hepatocyte cultures maintained in a serum-free medium formulation were susceptible to in vitro infection with HCV. In order to document infection, two new methods of reverse transcription/polymerase chain reaction were developed that permit accurate distinction between positive and negative strand HCV RNA. One method relied upon the use of a tagged cDNA primer, while the second method employed a thermostable reverse transcriptase. Following inoculation of chimpanzee hepatocytes with HCV, intracellular positive and negative strand HCV RNA were detectable 4 days postinfection and throughout the remainder of the experimental period, 25 days. Analysis of HCV-inoculated baboon hepatocytes revealed a total absence of negative strand HCV RNA, while residual positive strand RNA from the inoculum could be detected for up to 11 days. The in vitro replication of HCV RNA in chimpanzee hepatocytes could be suppressed by alpha-interferon. This system should be amenable to the study of HCV replication, antiviral compounds, and the development of neutralization assays.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030225     DOI: 10.1006/viro.1994.1381

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Antiviral genetic program is a new type of DNA vaccine.

Authors:  I G Sivov; A Sobolev; E I Samokhvalov; V I Sergienko
Journal:  Dokl Biochem Biophys       Date:  2001 Mar-Apr       Impact factor: 0.788

3.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Development of a strand specific real-time RT-qPCR assay for the detection and quantitation of murine norovirus RNA.

Authors:  Surender Vashist; Luis Urena; Ian Goodfellow
Journal:  J Virol Methods       Date:  2012-05-22       Impact factor: 2.014

5.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA.

Authors:  Eiryo Kawakami; Tokiko Watanabe; Ken Fujii; Hideo Goto; Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol Methods       Date:  2010-12-24       Impact factor: 2.014

7.  Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia.

Authors:  D Sansonno; F A Tucci; G Lauletta; V De Re; M Montrone; L Troiani; L Sansonno; F Dammacco
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

8.  Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses.

Authors:  T Laskus; M Radkowski; L F Wang; H Vargas; J Rakela
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  Novel function of CD81 in controlling hepatitis C virus replication.

Authors:  Yong-Yuan Zhang; Bai-Hua Zhang; Koji Ishii; T Jake Liang
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

10.  The native form and maturation process of hepatitis C virus core protein.

Authors:  K Yasui; T Wakita; K Tsukiyama-Kohara; S I Funahashi; M Ichikawa; T Kajita; D Moradpour; J R Wands; M Kohara
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.